Yahoo Web Search

Search results

1. finance.yahoo.com › news › clearmind-medicineClearmind Medicine Secures Exclusive Global Rights to ...

   finance.yahoo.com › news › clearmind-medicine

   • Cached

   May 7, 2024 · Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment Clearmind Medicine Inc. Tue, May 7, 2024, 7:46 AM 3 min read

2. finance.yahoo.com › news › clearmind-medicineClearmind Medicine Announces Closing of US$7.5 Million Public ...

   finance.yahoo.com › news › clearmind-medicine

   • Cached

   Nov 17, 2022 · Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market. Clearmind Medicine Inc. Thu, Nov 17, 2022, 11:43 AM 5 min read.

3. finance.yahoo.com › news › clearmind-medicineClearmind Medicine Obtains Clearance for its Psychedelic ...

   finance.yahoo.com › news › clearmind-medicine

   • Cached

   Mar 13, 2024 · Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a clinical- stage biotech company focused on...

4. People also ask

   Who is clearmind medicine?

   • About Clearmind Medicine Inc. Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder.

   Clearmind Medicine

   www.clearmindmedicine.com/news-release/clearmind-medicine-announces-closing-of-us-7-5-million-public-offering-and-uplisting-to-the-nasdaq-capital-market

   See all results for this question

   What is clearmind's cmnd-100 clinical trial?

   • The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial. The clinical trial is a multinational, multi-center, single and multiple dose tolerability, safety and pharmacokinetic study of CMND-100 in healthy volunteers and AUD subjects.

   Clearmind Medicine Obtains Clearance for its Psychedelic- Based

   finance.yahoo.com/news/clearmind-medicine-obtains-clearance-psychedelic-121400469.html

   See all results for this question

   Where can I buy shares of clearmind?

   • Shares of Clearmind are listed for trading on the Nasdaq and Canadian Securities Exchange under the symbol “ CMND ”, and the Frankfurt Stock Exchange under the symbol “ CWY ”. For further information, please contact: Investor Relations, Email: invest@clearmindmedicine.com Telephone: (604) 260-1566 General Inquiries, Info@Clearmindmedicine.com

   Clearmind Medicine

   www.clearmindmedicine.com/news-release/clearmind-medicine-announces-closing-of-us-7-5-million-public-offering-and-uplisting-to-the-nasdaq-capital-market

   See all results for this question

   Why is clearmind launching a FIH clinical trial?

   • The clinical batches production is made possible due to prior successful production of MEAI drug substance that was used in the Company's pre-clinical studies designed to evaluate the safety of its innovative compound. "Clearmind continues its progress toward FIH clinical trial" said Dr. Adi Zuloff-Shani, Clearmind's Chief Executive Officer.

   Clearmind Medicine

   www.clearmindmedicine.com/news-release/clearmind-announces-initiation-of-cmnd-100-manufacturing-program-to-address-its-upcoming-clinical-trial

   See all results for this question

5. www.clearmindmedicine.com › news-release › clearmindClearmind Medicine

   www.clearmindmedicine.com › news-release › clearmind

   • Cached

   Nov 17, 2022 · November 17, 2022. VANCOUVER, Nov. 17, 2022 -- Clearmind Medicine Inc. (Nasdaq and CSE: CMND ), (FSE: CWY) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the closing of its underwritten public ...

6. www.clearmindmedicine.com › news-release › clearmindClearmind Medicine

   www.clearmindmedicine.com › news-release › clearmind

   • Cached

   Mar 13, 2024 · Vancouver, Canada, March 13, 2024 -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND ), (FSE: CWY) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has received approval from the Israeli Minis...

7. www.clearmindmedicine.com › news-release › clearmindClearmind Medicine

   www.clearmindmedicine.com › news-release › clearmind

   • Cached

   Nov 23, 2022 · VANCOUVER, November 23, 2022 -- Clearmind Medicine Inc. (Nasdaq: CMND ), (CSE: CMND ), (FSE: CWY) (“ Clearmind ” or the " Company "), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the initiation of clinical batches of production of its...

8. www.nasdaq.com › press-release › clearmind-medicineClearmind Medicine Advances its Proprietary Psychedelic ...

   www.nasdaq.com › press-release › clearmind-medicine

   • Cached

   May 10, 2024 · --Clearmind Medicine Inc.,, a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces ...